{'fraction_non_alphanumeric': 0.027980535279805353, 'fraction_numerical': 0.009732360097323601, 'mean_word_length': 5.745901639344262, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical guidelines for mood disorders: The roads travelled, the road ahead

In December 2015, the Royal Australian and New Zealand College of Psychiatrists (RANZCP) published their latest clinical practice guidelines for mood disorders (Malhi et al., 2015). Recently, other guidelines on the same topic have been published by important scientific societies: the British Association of Psychopharmacology (BAP) and the Canadian Network for Mood and Anxiety Treatments (CANMAT). Each guideline stemmed from a meeting of experts, which identified relevant new literature, consensus points and areas of uncertainty. In this commentary, we compare these clinical guidelines, considering why multiple organizations publish guidance on similar topics and discussing what might be done to improve such publications in the future.